Gaeta Renee sold $87K of OM
Gaeta Renee (Chief Financial Officer) sold 17,672 shares of Outset Medical, Inc. (OM) at $4.94 on 2026-06-03.
How this was made
The 30-second read
Why it matters
Traders may monitor whether additional insider activity follows, but the disclosure alone does not change the company’s fundamentals.
Market read
A disclosed CFO open-market sale can slightly pressure sentiment, but it is not a standalone fundamental driver.
What to watch
The filing does not specify whether other insiders sold/bought around the same time, nor does it quantify proceeds relative to total holdings beyond the post-transaction share count.
Background
SEC Form 4 reports insider transactions; this filing is for Outset Medical CFO Gaeta Renee (direct open-market sale).
Ticker impact
Outset Medical CFO Gaeta Renee filed an open-market sale of 17,672 shares at $4.94 on 2026-06-03.
Low, likely limited to short-term sentiment/flow rather than a durable repricing.
This is an SEC Form 4 insider transaction disclosure with no 10b5-1 plan indicated; however, the filing provides no earnings, guidance, or deal information.
Market effects
Minimal—single-company insider sale without accompanying operational/regulatory news.
Minimal—no cross-region or macro linkage stated.
Minimal—no global deal or clinical/regulatory development mentioned.
Counterpoint
Because the sale is disclosed after execution and lacks a stated catalyst, it may reflect diversification or routine liquidity needs rather than bearish fundamentals.
Key entities
- issuerOutset Medical, Inc.
Subject of the insider transaction disclosure (OM).
- insiderGaeta Renee
Chief Financial Officer who sold 17,672 shares.


